|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1000520535 |
| 003 |
OCoLC |
| 005 |
20231120010212.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170814s2017 mau ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d YDX
|d IDEBK
|d EBLCP
|d N$T
|d OCLCF
|d UPM
|d D6H
|d VT2
|d UKMGB
|d OCLCA
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 066 |
|
|
|c $1
|
| 015 |
|
|
|a GBB7F1482
|2 bnb
|
| 016 |
7 |
|
|a 018470891
|2 Uk
|
| 019 |
|
|
|a 1001280333
|a 1050957962
|a 1235834730
|a 1262682283
|
| 020 |
|
|
|a 9780128117804
|q (electronic bk.)
|
| 020 |
|
|
|a 012811780X
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128117798
|q (print)
|
| 020 |
|
|
|z 0128117796
|
| 035 |
|
|
|a (OCoLC)1000520535
|z (OCoLC)1001280333
|z (OCoLC)1050957962
|z (OCoLC)1235834730
|z (OCoLC)1262682283
|
| 043 |
|
|
|a a-cc---
|
| 050 |
|
4 |
|a RM666.H33
|
| 060 |
|
4 |
|a QV 770 JC6
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.3/21
|2 23
|
| 245 |
0 |
0 |
|a Neurobiology of Chinese herb medicine /
|c edited by Bai-Yun Zeng and Kaicun Zhao.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press is an imprint of Elsevier,
|c 2017.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a International review of neurobiology ;
|v volume 135
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed August 16, 2017).
|
| 505 |
0 |
|
|a Front Cover; Neurobiology of Chinese Herb Medicine; Copyright; Contents; Contributors; Preface; Chapter One: Effects of Lycium barbarum on the Visual System; 1. Introduction; 1.1. Lycium barbarum; 1.2. The Visual System; 2. Effect of L. barbarum Polysaccharide Treatment in Animal Models of Retinal Disease; 2.1. Glaucoma; 2.2. Ischemia/Reperfusion Injury; 2.3. Age-Related Macular Degeneration; 2.4. Retinitis Pigmentosa; 2.5. Diabetic Retinopathy; 3. Underlying Mechanisms of L. barbarum Polysaccharides in the Retina; 3.1. Antioxidant Properties
|
| 505 |
8 |
|
|a 3.2. Modulation of the Blood Vessels/Vascularization3.3. Neuroprotection; 3.4. Immunomodulation; 3.5. Links Between the Visual System and Internal Organ Health in CHM; 4. L. barbarum Polysaccharide as a Treatment and Preventative Medicine: Future Perspectives and Conclusions; Acknowledgments; References; Chapter Two: Effect of Chinese Herbal Medicine on Alzheimer's Disease; 1. Introduction; 1.1. Alzheimer's Disease; 1.2. Ethnopharmacology; 1.3. TCM and AD; 2. Plants Used Traditionally for AD-Like Symptoms; 2.1. Acorus calamus; 2.2. Gastrodia elata; 2.3. Huperzia serrata; 2.4. Panax ginseng
|
| 505 |
8 |
|
|a 2.5. Polygala Species2.6. Rehmannia glutinosa; 3. Plants Used Traditionally but Not for AD-Like Symptoms: Evidence for Relevant Activity; 3.1. Crocus sativus; 3.2. Epimedium Species; 3.3. Ginkgo biloba; 3.4. Magnolia officinalis; 3.5. Salvia miltiorrhiza; 4. CHM Formulas Relevant to AD; 5. Conclusion; Acknowledgments; References; Chapter Three: Effect and Mechanism of Chinese Herbal Medicine on Parkinson's Disease; 1. Introduction; 2. Mechanism of Action of Extracts/Compounds From Chinese Herbs on Parkinson's Model; 2.1. Antioxidant; 2.2. Antiapoptosis; 2.3. Antiinflammation
|
| 505 |
8 |
|
|a 2.4. Monoamine Oxidase-B Inhibition2.5. Antidyskinesia; 2.6. Multiple Targets; 3. Mechanism of Action of Chinese Herbal Formula on Parkinson's Model; 4. Clinical Study of CHM on Parkinson's Disease; 5. Future Research of CHM in Parkinsons; Acknowledgment; References; Chapter Four: Neurobiology of Chinese Herbal Medicine on Major Depressive Disorder; 1. Introduction; 2. TCM View on Depression; 3. Clinical Findings Demonstrated the Antidepressant Efficacy of CHM; 4. Neurobiological Mechanisms of Antidepressant Effects of CHM; 4.1. Enhancement of Monoamine; 4.2. Dehyperactivation of HPA Axis
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Herbs
|x Therapeutic use
|z China.
|
| 650 |
|
0 |
|a Neurobiology.
|
| 650 |
|
0 |
|a Medicine, Chinese.
|
| 650 |
0 |
2 |
|a Drugs, Chinese Herbal
|x therapeutic use
|0 (DNLM)D004365Q000627
|
| 650 |
0 |
2 |
|a Neurobiology
|0 (DNLM)D009446
|
| 650 |
0 |
2 |
|a Medicine, Chinese Traditional
|x methods
|0 (DNLM)D008516Q000379
|
| 650 |
|
2 |
|a Medicine, Chinese Traditional
|0 (DNLM)D008516
|
| 650 |
|
6 |
|a Herbes
|0 (CaQQLa)201-0060544
|x Emploi en th�erapeutique
|0 (CaQQLa)201-0060544
|z Chine.
|0 (CaQQLa)201-0476619
|
| 650 |
|
6 |
|a Neurobiologie.
|0 (CaQQLa)201-0010246
|
| 650 |
|
6 |
|a M�edecine chinoise.
|0 (CaQQLa)201-0046420
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Herbs
|x Therapeutic use.
|2 fast
|0 (OCoLC)fst00955386
|
| 650 |
|
7 |
|a Medicine, Chinese.
|2 fast
|0 (OCoLC)fst01015214
|
| 650 |
|
7 |
|a Neurobiology.
|2 fast
|0 (OCoLC)fst01036315
|
| 651 |
|
7 |
|a China.
|2 fast
|0 (OCoLC)fst01206073
|
| 700 |
1 |
|
|a Zeng, Bai-Yun,
|e editor.
|
| 700 |
1 |
|
|a Zhao, Kaicun,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Neurobiology of Chinese herb medicine.
|d Cambridge, MA : Academic Press is an imprint of Elsevier, 2017
|z 9780128117798
|z 0128117796
|w (OCoLC)974699162
|
| 830 |
|
0 |
|a International review of neurobiology ;
|v v. 135.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/00747742/135
|z Texto completo
|
| 880 |
8 |
|
|6 505-00/$1
|a 3.4. Baizhu (Atractylodes macrocephala 白术)
|
| 880 |
8 |
|
|6 505-00/$1
|a 4.3. Neuroimmune Response4.4. Metabolic Alternation; 4.5. Neurotrophic Factors; 5. Neurobiological Mechanisms of Rapid and Persistent Antidepressant Effects of CHM; 6. Conclusion and Outlook; Acknowledgments; References; Chapter Five: Treatment of Insomnia With Traditional Chinese Herbal Medicine; 1. Introduction; 2. Clinical Applications of Chinese Medicinal Herbs and Formulas for Treatment of Insomnia; 3. Potential Effective Herbs and Pharmacological Action Mechanisms; 3.1. Suanzaoren (Ziziphi spinosae 枣仁); 3.2. Danshen (Salviae miltiorrhizae 丹参); 3.3. Yuanzhi (Polygala tenuifolia 志)
|
